Revenue segments as reported by the company.

Premiums

Products

Services

Investment and other income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Medical costs

Operating costs

Depreciation and amortization

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

UnitedHealth Group

Optum is a Health Services platform. It is a leading information and technology-enabled health services business dedicated to modernizing the system and improving the health of people and communities.

Optum

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

UnitedHealth Group reports strong Q4 earnings and growth opportunities

UnitedHealth Group's Q4 2022 Earnings Call highlighted strong financial performance, growth initiatives, and confidence in sustainable earnings growth. The company is focused on enhancing consumer experiences, expanding value-based care, and driving growth through strategic investments and M&A priorities. Challenges include managing cost impacts from flu and respiratory issues, while opportunities lie in continued growth in key segments and strategic M&A.

UnitedHealth Group reports robust Q1 earnings, eyes growth opportunities

UnitedHealth Group's strong performance in Q1 2023 reflects growth across its segments, driven by a focus on value-based care and consumer-centric initiatives. While challenges exist with potential Medicare Advantage model changes, the company remains optimistic about sustained growth and opportunities for expansion.

UnitedHealth Group posts robust Q2 earnings, eyes tech-driven growth

UnitedHealth Group delivered strong financial performance in Q2 2023, with a focus on expanding patient care, driving cost efficiencies, and responding to changing healthcare dynamics. Challenges include margin pressures and managing investment gains unpredictability. Opportunities lie in leveraging technology for cost reduction and enhancing care capabilities post acquisitions.

UnitedHealth Group reports robust Q3 growth, eyes expansion in value-based care

UnitedHealth Group's Q3 performance showcased robust revenue growth and strengthened earnings outlook. The company's focus on value-based care, strong performance in pharmacy services, and investments in home care present opportunities for future growth. However, challenges related to wage inflation and margin impact at Optum Health require attention.

UnitedHealth Group posts strong 2023 results, eyes growth opportunities

UnitedHealth Group's 2023 performance showcased robust financial results, strategic investments in digital engagement, and a focus on improving healthcare quality and accessibility. While facing challenges in cost trends and industry dynamics, the company remains optimistic about its competitive positioning and growth prospects in 2024.

UnitedHealth Group resilient post-cyberattack, eyes growth opportunities

UnitedHealth Group navigated cyberattack impacts while maintaining outlook.
Strong response to challenges, focusing on growth and customer support.
Balanced approach to capital deployment and confidence in future opportunities.
Optimism in controlling costs and driving growth through innovation.

UnitedHealth Group reports resilient growth amidst cyberattack challenges

UnitedHealth Group's Q2 2024 performance reflects resilience and growth potential despite challenges from a cyberattack and other disruptions.
The company's strengths in customer recognition, Medicare Advantage programs, and technology innovation position it well for future success and market expansion.
While facing challenges like cyberattack impacts and medical care ratio issues, UnitedHealth Group remains focused on opportunities for growth and returning to baseline performance in 2025.

UnitedHealth Group affirms growth outlook amidst challenges, eyes 2025 strategy

UnitedHealth Group's Q3 2024 performance reflects strong revenue growth and a commitment to value-based care and innovation. Despite challenges like cyberattacks and care patterns impacting earnings outlook, the company remains focused on long-term growth objectives. UNH's strategic investments, focus on consumer experience, and capital deployment priorities signal a proactive approach to driving future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Brian Thompson—the 50-year-old CEO of the health insurance division of the $550 billion UnitedHealth Group—was killed Wednesday in what police reportedly believe was a targeted shooting in Manhattan ahead of an investor meeting.

Who Is Brian Thompson? UnitedHealthcare CEO Fatally Shot In NYC

Brian Thompson, the CEO of UnitedHealthcare, was fatally shot in Midtown Manhattan early Wednesday morning while walking toward the New York Hilton Midtown for his company's annual investor conference. According to emerging media reports, Thompson was fired on from roughly 20 feet away by a masked gunman who appeared to be waiting for Thompson and who escaped by bicycle.

UnitedHealthcare CEO Brian Thompson shot and killed in New York

UnitedHealth Group was scheduled to host its annual Investor Day Wednesday but the event was cancelled following the fatal shooting of its insurance unit CEO.

UnitedHealth Cancels Investor Day After Executive Brian Thompson Is Shot

An executive at a major US healthcare company has been shot dead in Manhattan.

US healthcare executive shot dead outside Manhattan hotel

Brian Thompson was shot in the chest and leg shortly before UnitedHealthcare was set to hold its annual investors meeting.

UnitedHealth ExecutiveShot Dead Outside Manhattan Hotel

UnitedHealth Group cut short its investor day after the fatal shooting of a top executive in midtown Manhattan. The post UnitedHealth Group Top Exec Fatally Shot; UNH Cuts Short Investor Conference appeared first on Investor's Business Daily.

UnitedHealth Group Top Exec Fatally Shot; UNH Cuts Short Investor Conference

The CEO of UnitedHealthcare, Brian Thompson, was fatally shot in Manhattan Wednesday morning, outside of the New York Hilton Midtown, according to the New York Police Department.

UnitedHealthcare CEO Fatally Shot In New York, NYPD Says

Thompson headed up the health benefits unit of UnitedHealth Group

UnitedHealthcare executive Brian Thompson shot and killed in New York City

UnitedHealth cancels investor day after reports of executive shot in Manhattan

The CEO of UnitedHealthcare, Brian Thompson, was fatally shot in the chest on Wednesday morning outside the Hilton hotel in Midtown, NY Post reported, citing police sources.

UnitedHealthcare CEO fatally shot, NY Post reports

UnitedHealth on Wednesday forecast medical costs for 2025 above Wall Street expectations as it expects high demand for healthcare services in its government-backed insurance businesses to persist.

UnitedHealth forecasts 2025 medical costs above expectations

Brian Thompson—the 50-year-old CEO of the health insurance division of the $550 billion UnitedHealth Group—was killed Wednesday in what police believe was a targeted shooting in Manhattan after his wife said he'd received threats related to his work.

Who Is Brian Thompson? UnitedHealthcare CEO Fatally Shot After Being Threatened

UnitedHealth on Tuesday forecast adjusted profit for 2025 below Wall Street estimates.

UnitedHealth forecasts 2025 profit below estimates

--(BUSINESS WIRE)--UNH Updates Business Outlook Ahead of Investor Conference.

UnitedHealth Group Updates Business Outlook Ahead of Investor Conference

UnitedHealth Group (UNH) closed the most recent trading day at $608.52, moving -0.28% from the previous trading session.

UnitedHealth Group (UNH) Stock Slides as Market Rises: Facts to Know Before You Trade

Accenture Plc

Amphenol

Canadian National Railway Company

Domino's Pizza

Elevance Health Inc

Global Payments

Intuit

Lam Research

Monolithic Power Systems

MSCI

Nordson

ResMed

Rollins

SPDR S&P 500 ETF Trust

Vanguard Dividend Appreciation ETF

Zoetis

The SPDR S&P 500 ETF Trust posted a strong gain of 5.96% in November, resuming its strong run in 2024. The Top 15 dividend growth stocks for December 2024 offer an average dividend yield of 1.2% and appear to be about 22% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved a 12.41% compound annual growth rate.

My Top 15 High-Growth Dividend Stocks For December 2024

In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $606.79, denoting a +0.16% change from the preceding trading day.

UnitedHealth Group (UNH) Ascends But Remains Behind Market: Some Facts to Note

UNH's success marks the third recent defeat for CMS in star ratings lawsuits, raising hopes for Humana and Centene as they challenge their own ratings.

Recalculation Ahead: Implications of UnitedHealth's Win Against CMS

--(BUSINESS WIRE)--UnitedHealth Group to Host 2024 Investor Conference.

UnitedHealth Group to Host 2024 Investor Conference

UnitedHealth rose after a federal judge ordered a rerating of the Dow Jones giant's Medicare Star Ratings. The post UnitedHealth Rises On Medicare Star Ratings Ruling; Humana Rallies appeared first on Investor's Business Daily.

UnitedHealth Rises On Medicare Star Ratings Ruling; Humana Rallies

UnitedHealth Group is a dividend growth stock on its way to becoming a Dividend Aristocrat. The company delivered yet another double beat in the third quarter. UnitedHealth Group's net debt to adjusted EBITDA ratio is just above 1, which supports an A+ credit rating from S&P on a stable outlook.

UnitedHealth Group: Now A Fairly Valued Dividend-Growth Machine

UnitedHealth Group has underperformed the broader market in 2024 but shows potential for bullish activity in 2025 despite regulatory uncertainties. UNH delivered strong Q3 results with EPS of $7.15, beating expectations, and revenue of $101 billion, driven by higher service usage. Risks include policy uncertainty and potential premium increase restrictions, but the stock remains slightly undervalued with a target price near $618.

UnitedHealth: Navigating Policy Uncertainty Well, Solid EPS Growth Ahead

UnitedHealthcare navigates regulatory challenges, rising medical costs, and a cyberattack, maintaining growth and positioning for long-term success in a resilient healthcare sector. Despite temporary headwinds, UNH targets 13%-16% long-term earnings growth, supported by rising health expenditures and technological advancements. Optum Insight and Optum Health segments face short-term hurdles but are poised for future growth, enhancing UNH's value-based care strategy.

UnitedHealth Group: Preparing For December Investor Day, Buy Reiterated

Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know

FedEx

Visa

3 Dividend Growth Stocks That Have Increased Their Payouts by More Than 90% in 5 Years

News for UnitedHealth Group Stock (UNH)